Prevalence of endocrine complications in β-thalassaemia major in the Islamic Republic of Iran

Eastern Mediterranean Health Journal

Volumn 9, Issue 1-2, 2003, Pages 55-60

  Karamifar, H ^a   Shahriari, M ^a   Sadjadian, N ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; DEFEROXAMINE; FERRITIN; IRON CHELATING AGENT;

ADOLESCENT; ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; EARLY DIAGNOSIS; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; FUNCTIONAL ASSESSMENT; HUMAN; HYPOPARATHYROIDISM; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; IRAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PANCREAS FUNCTION; PARATHYROID FUNCTION; PEDIATRIC HOSPITAL; PREVALENCE; THALASSEMIA MAJOR; THYROID FUNCTION; TISSUE INJURY; TREATMENT PLANNING; UNIVERSITY HOSPITAL; AFTERCARE; BLOOD; BLOOD TRANSFUSION; GROWTH DISORDER; HEALTH SURVEY; NEEDS ASSESSMENT; RISK FACTOR; STANDARD;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; AFTERCARE; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; DEFEROXAMINE; DIABETES MELLITUS, TYPE 1; FEMALE; FERRITINS; GROWTH DISORDERS; HOSPITALS, UNIVERSITY; HUMANS; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IRAN; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; NEEDS ASSESSMENT; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS;

EID: 16544381555     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Grundy RG et al. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Archives of disease in childhood, 1994, 71:128-32.
2. Sklar CA et al. Adrenal function in thalassemia major following long-term treatment with multiple transfusions and chelation therapy. Evidence for dissociation of cortisol and adrenal androgen secretion. American journal of diseases of children, 1987, 141:327-30.
3. Low LC. Growth, puberty and endocrine function in beta-thalassaemia major. Journal of pediatric endocrinology & metabolism, 1997, 10:175-84.
4. Pintor C et al. Impaired growth hormone (GH) response to GH-releasing hormone in thalassaemia major. Journal of clinical endocrinology & metabolism, 1986, 62:263-7.
5. Cavallo L et al. Growth deficiency in polytransfused β -thalassaemia patients is not growth hormone dependent. Clinical endocrinology, 1997, 46:701-6.
6. Sabato AR et al. Primary hypothyroidism and the low T3 syndrome in thalassaemia major. Archives of disease in childhood, 1983, 58:120-4.
7. Costin G et al. Endocrine abnormalities in thalassemia major. Archives of disease in childhood, 1979, 133:497-502.
8. Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. Journal of pediatric endocrinology & metabolism, 2000, 13:651-6.
9. Costin G et al. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major. Diabetes, 1977, 26: 230-40.
10. Modell B et al. Survival and desferrioxamine in thalassaemia major. British medical journal, 1982, 284:1081-4.
11. Gamberini MR, et al. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients. Journal of pediatric endocrinology & metabolism, 1998, 11(suppl. 3):867-9.
12. Sperling MA. Diabetes mellitus in children. In: Behrman RE, Klegman RM, Jenson HB, eds. In: Nelson textbook of pediatrics, 16th ed. Philadelphia, WB Saunders Company, 2000:1768.
13. Orth DN, Kovacs WJ. The adrenal cortex. In: Wilson JD, Foster DW, Kranenberg HM, eds. In: Williams textbook of endocrinology, 9th ed. Philadelphia, WB Saunders Company, 1998:558.
14. Jensen CE et al. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. European journal of haematology 1997, 59:76-81.
15. De Sanctis V et al. Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients. Acta haematologica, 1992, 88:105-8.
16. De Sanctis V et al. Insulin dependent diabetes in thalassaemia. Archives of disease, 1988, 63:58-62.
17. Rahier J et al. The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study. Diabetologia, 1987, 30:5-12.
18. Weintraub LR et al. Collagen biosynthesis in iron overload. Annals of the New York Academy of Sciences, 1988, 526: 179-84.
19. Aldouri MA et al. Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. Journal of clinical pathology, 1987, 40:1353-9.